Millennium Management’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Millennium Management’s Portfolio NBRV Stock Details NBRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,966	Closed	-$118K	–	7875
2021 Q3	$118K	Buy	3,966 +2,721	+219%	+$76.8K	﹤0.01%	6365
2021 Q2	$42K	Buy	+1,245	New	+$46.4K	﹤0.01%	6389
2020 Q4	–	Sell	-153	Closed	-$20	–	5825
2020 Q3	$20	Buy	+153	New	+$25.6K	﹤0.01%	4352
2019 Q4	–	Sell	-1,333	Closed	-$666K	–	4827
2019 Q3	$666K	Buy	1,333 +195	+17%	+$110K	﹤0.01%	3078
2019 Q2	$692K	Buy	1,138 +784	+221%	+$481K	﹤0.01%	3031
2019 Q1	$216K	Sell	354 -128	-27%	-$69.8K	﹤0.01%	3700
2018 Q4	$176K	Sell	482 -11	-2%	-$5.92K	﹤0.01%	3426
2018 Q3	$333K	Buy	+493	New	+$349K	﹤0.01%	3438
2018 Q2	–	Sell	-3,292	Closed	-$4.14M	–	4348
2018 Q1	$4.14M	Sell	3,292 -178	-5%	-$263K	0.01%	1920
2017 Q4	$5.19M	Buy	+3,470	New	+$5.49M	0.01%	1726
2017 Q3	–	Sell	-292	Closed	-$764K	–	4031
2017 Q2	$764K	Buy	+292	New	+$753K	﹤0.01%	2588
2016 Q1	–	Sell	-77	Closed	-$185K	–	3809
2015 Q4	$185K	Sell	77 -69	-47%	-$168K	﹤0.01%	3118
2015 Q3	$348K	Buy	+146	New	+$387K	﹤0.01%	2838

Other funds holding NBRV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management's NBRV Position: Q4 2021 in Review

Millennium Management sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q4 2021, closing a stake of 3,966 shares — an estimated $118K sold.

Millennium Management first reported a position in NBRV in Q3 2015 and held it in 13 quarters. The position peaked at $5.19M in Q4 2017. 34 funds tracked by Wall St. Rank hold NBRV as of Q4 2021.

Millennium Management reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q4 2021 after selling out during the quarter.
Millennium Management sold 3,966 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q4 2021, an estimated $118K.
Millennium Management first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2015 and held it in 13 quarters.
Millennium Management's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $5.19M in Q4 2017.
34 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q4 2021.

Based on Millennium Management's 13F filing for Q4 2021, filed 14 Feb 2022.